Related Experiment Video
Updated: Sep 15, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
In-silico trials of targeted screening for abdominal aortic aneurysms using linked healthcare data: A study protocol
Liam Musto1, Athanasios Saratzis1, Mintu Nath1
1Department of Cardiovascular Sciences, NIHR Leicester Biomedical Research Centre and BHF Centre for Research Excellence, University of Leicester, Glenfield Hospital, Leicester, United Kingdom.
Targeted screening for abdominal aortic aneurysms (AAA) in high-risk men could improve upon current NHS screening policies. This research will assess the clinical outcomes and cost-effectiveness of this approach.
Area of Science:
- Vascular Surgery
- Public Health
- Health Economics
Background:
- The National Health Service (NHS) abdominal aortic aneurysm (AAA) screening programme (NAAASP) is effective but faces declining disease prevalence.
- Decreasing AAA prevalence reduces the efficiency of the current NAAASP policy.
- Targeted screening of high-risk groups is a potential alternative, but its clinical and economic viability is unknown.
Purpose of the Study:
- To estimate the clinical outcomes of targeted AAA screening.
- To assess the cost-effectiveness of targeted AAA screening compared to the current whole-population strategy.
Main Methods:
- In-silico trials using linked NAAASP and Clinical Practice Research Datalink (CPRD) data (approx. 2,500,000 men).
- Development of a risk prediction model to identify high-risk criteria for targeted screening.
- Qualitative evidence synthesis to explore acceptability issues of targeted screening.
- Discrete event simulation to extrapolate findings and estimate cost-effectiveness.
Main Results:
- Diagnostic accuracy of risk prediction models for identifying AAA in silico.
- Comparison of clinical outcomes and cost-effectiveness between targeted and whole-population screening.
Conclusions:
- This research is expected to significantly impact AAA screening policies globally.
- Findings will inform future NHS, UK, and worldwide AAA screening strategies.
More Related Videos
10:09Drug Treatment by Central Venous Catheter in a Mouse Model of Angiotensin II Induced Abdominal Aortic Aneurysm and Monitoring by 3D Ultrasound
Published on: August 4, 2022
05:07Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm
Published on: August 2, 2024
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care